Please use this identifier to cite or link to this item:
http://essuir.sumdu.edu.ua/handle/123456789/69748
Or use following links to share this resource in social networks:
Tweet
Recommend this item
Title | Osteonectin overexpression in the case of prostate cancer with intraluminal inclusions |
Authors |
Piddubnyi, Artem Mykhailovych
![]() Moskalenko, Roman Andriiovych ![]() Radomychelski, I.-M. Lyndin, Mykola Serhiiovych ![]() Sikora, Vladyslav Volodymyrovych ![]() Romaniuk, Anatolii Mykolaiovych ![]() |
ORCID |
http://orcid.org/0000-0002-6508-0131 http://orcid.org/0000-0002-2342-0337 http://orcid.org/0000-0003-4385-3903 http://orcid.org/0000-0002-4147-6879 http://orcid.org/0000-0003-2560-1382 |
Keywords |
рак передміхурової залози рак предстательной железы prostate cancer інтралюмінальні включення интралюминальные включения intraluminal inclusions простатоліти простатолиты prostate calculi corpora amylacea імуногістохімія иммуногистохимия immunohistochemistry біомінералізація биоминерализация biomineralization остеонектин osteonectin |
Type | Conference Papers |
Date of Issue | 2018 |
URI | http://essuir.sumdu.edu.ua/handle/123456789/69748 |
Publisher | Virchows Archiv |
License | Copyright not evaluated |
Citation | Osteonectin overexpression in the case of prostate cancer with intraluminal inclusions / A. Piddubnyi, R. Moskalenko, I. Radomychelski [et al.] // Virchows Archiv. – 2018. – № 473. – P. S45. |
Abstract |
Osteonectin (OSN) is secreted by osteoblasts during bone formation, initiating mineralization and promoting mineral crystal formation at sites of ectopic calcification. Also OSN was found in many types of human malignant tumours.
The aim is to study the OSN expression in patients with prostate cancer (PC) and the presence of intraluminal inclusions (prostatolithes and amyloid cells).
Method: OSN expression was investigated in tumours and in the adjacent prostatic tissue of 30 PCs with intraluminal inclusions and 30 PCs without them by immunohistochemistry. In each group 15 samples refer to moderately differentiated G2 and low-differentiated G3 tumours. Samples were fixed, embedded in paraffin, and analized for OSN accumulation using the anti-OSN antibody, followed by DAB detection substrate and counterstained with Mayer’s haematoxylin.
Results: OSN expression was increased in PC tissues with pathological inclusions in comparison to those without them (p<0.001, Student test). Osteonectin was mostly localized in tumour cells cytoplasm, its expression was not observed in tumour microangiourea cells and in stroma. It was found that the OSN expression by tumour cells reduced during reduction of the malignant tumour differentiation (comparison of subgroups G2 and G3) (p<0.001 and p<0.01 respectively for groups I and II).
Conclusion: OSN overexpression in tumours and in the adjacent prostatic tissue of PCs with intraluminal inclusions may be regarded as a prospective role for the osteosteogenic phenotype development of tumour cells and for the bone metastasis promotion. |
Appears in Collections: |
Наукові видання (НН МІ) |
Views

1

397

1517497698

390103

1

1

-1226425155

111689615

56426307

1517497700

1747984014

10563
Downloads

1

1

1

324619287

1162999

-1226425155

18

1
Files
File | Size | Format | Downloads |
---|---|---|---|
Piddubnyi_OSN_ECP-2018.pdf | 61.86 kB | Adobe PDF | -900642847 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.